Impact Factor
2.61
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.24
309 total citations
h5-index
24
h5 depth signal
Cited share
33.2%
83 of 250
Total citations
309
Citation footprint
Metric signal
1.11
External metric anchor
Self-citation
1.6%
5 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
542
China
36
Canada
36
United Kingdom
17
Australia
12
Citing Fields of Research
Substance Abuse
585
Anesthetic & Pain Medicine
105
Psychiatry
101
Psychiatry & Psychology
81
Nicotine Addiction Treatment
81
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,592
Articles tracked across the journal lifetime
Indexed publication set
250
83 cited publications
Last 12 months
115
9.6 publications/month
Open access share
19.1%
22 OA publications in the last year
Leading citing country
United States
542 citing publications
Leading citing field
Substance Abuse
585 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v6n1,winter 1997-
v6n1,winter 1997-
Active Coverage
Research Focus & Classification
Indexed Subjects
Substance Abuse
Issuing & Sponsoring Bodies
Contributor
American Academy of Psychiatrists in Alcoholism & Addictions
Contributor
American Academy of Addiction Psychiatry
Broad Categories
Substance-Related Disorders
Substance Abuse
MeSH Descriptors
Behavior, Addictive
Substance-Related Disorders
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/ajad.70216
Open DOI
Norfentanyl detection after negative confirmatory testing following heavy illicit fentanyl exposure: A two‐patient case series
Background and Objectives: Prolonged fentanyl detection may complicate urine drug testing (UDT). We describe norfentanyl detection after negative confirmatory testing. Methods: Two patients ( N = 2) entering residential treatment after h...
02
DOI 10.1111/ajad.70205
Open DOI
Treating co‐occurring alcohol use disorder and major depressive disorder: A systematic review of combination and multimodal pharmacotherapy
Background and Objectives: Major depressive disorder (MDD) and alcohol use disorder (AUD) frequently co‐occur and are associated with greater symptom severity and elevated suicide risk relative to either disorder alone, yet no pharmacolo...
03
DOI 10.1111/ajad.70203
Open DOI
Gambling behaviors associated with problem gambling among patients in treatment for substance use disorder
Background and Objectives: Problem gambling impacts substance use disorder (SUD) treatment outcomes. To support early intervention, this study investigated gambling behaviors associated with problem gambling among SUD patients. Methods: ...
04
DOI 10.1111/ajad.70204
Open DOI
Evidence‐based harm reduction training via ECHO: A mentor facilitated educational training for behavioral health providers
Background and Objectives: Harm reduction strategies are essential to reducing morbidity and mortality associated with substance use disorders (SUD), yet many healthcare providers report limited training, knowledge gaps, and low confiden...
05
DOI 10.1111/ajad.70201
Open DOI
Opioid withdrawal syndrome‐associated cognitive impairment: A narrative review
Background and Objectives: Opioid withdrawal syndrome (OWS) comprises a transient constellation of subjective symptoms and objective signs expressed by brain and other organs. Although cognitive impairment is well documented in opioid us...
06
DOI 10.1111/ajad.70200
Open DOI
How common is alcohol use disorder in posttraumatic stress disorder? A systematic review, meta‐analysis, and moderator analysis
Background and Objectives: Comorbidity between posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) complicates care, yet reported prevalence varies widely across settings and methods. We estimated AUD prevalence among adu...
07
DOI 10.1111/ajad.70199
Open DOI
Clinical applications of wearable devices for individuals with at‐risk substance use and substance use disorders: A systematic review
Background and Objectives: Managing substance use disorders (SUDs) is limited by the lack of longitudinal clinical data during active use and recovery. Wearable devices may help address this gap by capturing physiological and behavioral ...
08
DOI 10.1111/ajad.70202
Open DOI
Proof‐of‐concept trial of PP‐01 for mitigating cannabis withdrawal syndrome in participants with cannabis use disorder
Background and Objectives: Cannabis withdrawal symptoms can be severe and protracted, significantly impeding the ability to abstain from cannabis use, resulting in failed quit attempts and relapse. This clinical trial evaluated safety an...
09
DOI 10.1111/ajad.70190
Open DOI
Call for Special Issue Papers 2026
Click on the PDF file for live links
10
DOI 10.1111/ajad.70189
Open DOI
Issue Information
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 26, no. 6 (2014).
Also issued online.
Issued by the American Academy of Addiction Psychiatry, <2006->
Vol. 1, no. 1 (1992)19960820 Notice not published Printed on acid-free paper